Jason Tardio - Net Worth and Insider Trading

Jason Tardio Net Worth

The estimated net worth of Jason Tardio is at least $0 dollars as of 2024-11-05. Jason Tardio is the COO of Ovid Therapeutics Inc and owns about 0 shares of Ovid Therapeutics Inc (OVID) stock worth over $0. Details can be seen in Jason Tardio's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jason Tardio has not made any transactions after 2022-09-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jason Tardio

To

Jason Tardio Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jason Tardio owns 1 companies in total, including Ovid Therapeutics Inc (OVID) .

Click here to see the complete history of Jason Tardio’s form 4 insider trades.

Insider Ownership Summary of Jason Tardio

Ticker Comapny Transaction Date Type of Owner
OVID Ovid Therapeutics Inc 2022-09-12 Chief Commercial Officer

Jason Tardio Latest Holdings Summary

Jason Tardio currently owns a total of 1 stock. Jason Tardio owns 0 shares of Ovid Therapeutics Inc (OVID) as of September 12, 2022, with a value of $0.

Latest Holdings of Jason Tardio

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OVID Ovid Therapeutics Inc 2022-09-12 0 1.25 0

Holding Weightings of Jason Tardio


Jason Tardio Form 4 Trading Tracker

According to the SEC Form 4 filings, Jason Tardio has made a total of 1 transactions in Ovid Therapeutics Inc (OVID) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Ovid Therapeutics Inc is the sale of 17,344 shares on September 12, 2022, which brought Jason Tardio around $37,290.

Insider Trading History of Jason Tardio

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jason Tardio Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jason Tardio Ownership Network

Ownership Network List of Jason Tardio

No Data

Ownership Network Relation of Jason Tardio

Insider Network Chart

Jason Tardio Owned Company Details

What does Ovid Therapeutics Inc do?

Who are the key executives at Ovid Therapeutics Inc?

Jason Tardio is the Chief Commercial Officer of Ovid Therapeutics Inc. Other key executives at Ovid Therapeutics Inc include director & 10 percent owner & CEO Jeremy M Levin , 10 percent owner Takeda Pharmaceuticals U.s.a., Inc. , and CMO and PMO Amit Rakhit .

Ovid Therapeutics Inc (OVID) Insider Trades Summary

Over the past 18 months, Jason Tardio made no insider transaction in Ovid Therapeutics Inc (OVID). Other recent insider transactions involving Ovid Therapeutics Inc (OVID) include a net purchase of 18,248 shares made by Jeremy M Levin ,

In summary, during the past 3 months, insiders sold 0 shares of Ovid Therapeutics Inc (OVID) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ovid Therapeutics Inc (OVID) were sold and 18,248 shares were bought by its insiders, resulting in a net purchase of 18,248 shares.

Ovid Therapeutics Inc (OVID)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ovid Therapeutics Inc Insider Transactions

No Available Data

Jason Tardio Mailing Address

Above is the net worth, insider trading, and ownership report for Jason Tardio. You might contact Jason Tardio via mailing address: 1460 Broadway, New York Ny 10036.